News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

5,121 Results

Type

Article (222)
Press Release (4899)

Section

Business (1668)
Career Advice (6)
Deals (258)
Drug Delivery (2)
Drug Development (643)
Employer Resources (2)
FDA (98)
Job Trends (141)
News (2802)
Policy (284)

Tag

Date

Today (2)
Last 7 days (12)
Last 30 days (42)
Last 365 days (378)
2025 (42)
2024 (350)
2023 (269)
2022 (391)
2021 (375)
2020 (418)
2019 (420)
2018 (287)
2017 (267)
2016 (224)
2015 (261)
2014 (180)
2013 (111)
2012 (147)
2011 (178)
2010 (183)

Location

Africa (5)
Asia (212)
Australia (49)
California (60)
Canada (16)
China (4)
Europe (896)
Florida (7)
Maryland (7)
Massachusetts (101)
New York (9)
North Carolina (4)
Northern California (16)
Pennsylvania (11)
South America (11)
Southern California (32)
Tennessee (2)
Texas (2)

Filters

Type

Article (222)
Press Release (4899)

Section

Business (1668)
Career Advice (6)
Deals (258)
Drug Delivery (2)
Drug Development (643)
Employer Resources (2)
FDA (98)
Job Trends (141)
News (2802)
Policy (284)

Tag

Date

Today (2)
Last 7 days (12)
Last 30 days (42)
Last 365 days (378)
2025 (42)
2024 (350)
2023 (269)
2022 (391)
2021 (375)
2020 (418)
2019 (420)
2018 (287)
2017 (267)
2016 (224)
2015 (261)
2014 (180)
2013 (111)
2012 (147)
2011 (178)
2010 (183)

Location

Africa (5)
Asia (212)
Australia (49)
California (60)
Canada (16)
China (4)
Europe (896)
Florida (7)
Maryland (7)
Massachusetts (101)
New York (9)
North Carolina (4)
Northern California (16)
Pennsylvania (11)
South America (11)
Southern California (32)
Tennessee (2)
Texas (2)

5,121 Results for "basilea pharmaceutica".

Sort By

Business

Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation

Basilea Pharmaceutica Ltd announced that it has entered into an asset purchase agreement with the Glioblastoma Foundation Inc., for Basilea’s oncology drug candidate lisavanbulin, which has been developed as a potential therapy for glioblastoma, the most common type of primary brain cancer.

June 20, 2024
·
6 min read
Press Releases

Basilea provides portfolio update and outlook

January 8, 2025
·
7 min read
Press Releases

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

January 28, 2025
·
5 min read
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea

Basilea Pharmaceutica Ltd. announced that the continued strong sales performance of the antifungal Cresemba® by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the sales threshold triggering a USD 1.25 million milestone payment.

May 16, 2024
·
3 min read
Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics

Basilea Pharmaceutica Ltd announced that it has been awarded a grant from CARB-X, a global non-profit partnership dedicated to supporting the early development of antibacterial products.

April 9, 2024
·
4 min read
FDA

Basilea Wins FDA Approval for Antibiotic Ending 15-Year Regulatory Quest

Basilea Pharmaceutica received FDA approval for its antibiotic Zevtera in three indications Wednesday, finally getting the drug across the finish line a decade and a half after the agency rejected an earlier submission.

April 4, 2024
·
2 min read
·
Nick Paul Taylor
Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Basilea Pharmaceutica Ltd announced that scientific presentations with new data on its antibiotic ceftobiprole have been presented at ESCMID Global 2024, the annual meeting of the European Society of Clinical Microbiology and Infectious Diseases, which took place from April 27 to 30, 2024 in Barcelona, Spain.

May 3, 2024
·
11 min read
Press Releases

Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States

December 16, 2024
·
6 min read
Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio

Basilea Pharmaceutica Ltd announced its results for the financial year ended December 31, 2023.

February 13, 2024
·
9 min read
Basilea provides portfolio status update - Jan 05, 2024

Basilea Pharmaceutica Ltd reported on the progress within its R&D portfolio in 2023 and upcoming milestones and timelines.

January 5, 2024
·
7 min read

1 of 513

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin